Segments - Global Clinical Decision Support System (CDSS) Market by Models (Knowledge-based CDSS and Non-Knowledge CDSS), Modes of Delivery (Cloud-based and On-premise), Components (Hardware, Software, and Services), Products (Integrated CDSS and Standalone CDSS), Applications (Alerts & Reminders, Medical Diagnosis, Information Retrieval, Clinical Decision Support, and Others), User Interactivity (Active CDSS and Passive CDSS), End-users (Hospitals & Clinics, Ambulatory Surgical Centers, Nursing Homes, Elderly Care Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global Clinical Decision Support System (CDSS) market size was valued at around USD 1.7 billion in 2020 and is expected to reach more than USD 2.8 billion by 2028, expanding at a CAGR of around 9.4% during the forecast period, 2021 – 2028. The growth of the market is attributed to the rising demand for quality care and integrated reliable technical solutions.
A Clinical Decision Support System (CDSS) is referred as a health information technology, which provides knowledge regarding health in general and person-specific information to healthcare providers and patients for quality healthcare. CDSS comprises of a variety of tools such as clinical guidelines, condition-specific order sets, computerized alters and reminders, patient focused data reports and summaries, diagnostic support, and others. CDSS works as a supportive tool to enhance the quality of clinical decision-making by healthcare providers.
In last few years, there is significant surge in development and use of CDSS among hospitals and healthcare providers. Government initiatives to further increase adoption of CDSS in healthcare system are estimated to boost the clinical decision support system market. For example, the Health and Medicare Acts of the US government endorse CDSS by financially rewarding its integration into Electronic Health records (EHR). Emergence of COVID-19 pandemic has driven the demand for accurate diagnosis of vast number of patients across the globe boosting the CDSS market.
The report on the global clinical decision support system market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in
Attributes |
Details |
Report Title |
Clinical Decision Support System (CDSS) Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Models (Knowledge-based CDSS and Non-Knowledge CDSS), Modes of Delivery (Cloud-based and On-premise), Components (Hardware, Software, and Services), Products (Integrated CDSS and Standalone CDSS), Applications (Alerts & Reminders, Medical Diagnosis, Information Retrieval, Clinical Decision Support, and Others), User Interactivity (Active CDSS and Passive CDSS), End-users (Hospitals & Clinics, Ambulatory Surgical Centers, Nursing Homes, Elderly Care Centers, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
International Business Machines Corporation (IBM); Siemens Healthineers; Cerner Corporation; Koninklije Philips NV; Change Healthcare; Medical Information Technology, Inc. (Meditech); Allscripts Healthcare Solutions; General Electric Company; Wolters Kluwer NV; and Others |
Based on models, the market is bifurcated into knowledge based CDSS and non-knowledge CDSS. The knowledge-based segment accounts for a large share of the market. Growth of the segment attributes to usage of knowledge-based reasoning by healthcare providers to make clinical decisions. Integrating the knowledge-based systems into clinical workflow leads to less errors compared to non-knowledge systems.
On the basis of delivery modes, the market is divided into cloud-based and on-premise. The cloud-based segment is expected to expand due to increasing expenditure and adoption of cloud computing in healthcare. Cloud-based applications are operated in remote servers, do not depend on web browsers, and are less vulnerable to cyberattacks. Increased availability of cloud technology and its benefits are expected to drive the CDSS market over the forecast period.
Based on components, the market is divided into hardware, software, and services. The service segment is expected to witness significant growth during the forecast period. Continuous modification of software, availability of knowledge, and premium access to the advance and secure data affect the growth of the market positively.
On the basis of products, the market is divided into integrated CDSS and standalone CDSS. Integrating CDSS with EHR is expected to influence the growth of the market positively. Clinical decision support systems, when integrated with EHR, get database and history of patients from electronic health record and suggest medial solutions and medications to healthcare providers; thus, automating the clinical workflow. Increasing number of CDSS functions built into EHR systems is expected to support the growth of the segment and boost the market.
Based on applications, the market is segmented into alerts & reminders, medical diagnosis, information retrieval, clinical decision support, and others. The clinical decision support segment is expected to drive the market as the system provides treatment, diagnosis, and therapeutics guideline to healthcare providers to increase quality of care.
Based on user interactivity, the market is divided into active CDSS and passive CDSS. The passive CDSS segment offers evidence-based content and resources, which are to make knowledge enabled decisions is by healthcare providers. Growing usage of passive CDSS segment boosts the growth of the market.
On the basis of end-users, the market is segregated into hospitals & clinics, ambulatory surgical centers, nursing homes, elderly care centers, and others. The hospital & clinics segment is expected to drive the market owning to well-resourced diagnostic rooms, skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from various insurance companies.
Based on regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominates over the CDSS market owning to rising awareness among patients regarding the CDSS, ongoing advancement in technology, and increasing focus of government on providing better healthcare services. Market in Asia Pacific is expected to grow during the forecast period due to rapid digitization of healthcare industry, improving medical diagnostics facilities, and increasing government support in implementing CDSS in healthcare.
The global Clinical Decision Support Systems (CDSS) market is a well-diversified market with few dominant key players such as International Business Machines Corporation (IBM); Siemens Healthineers; Cerner Corporation; Koninklije Philips NV; Change Healthcare; Medical Information Technology, Inc. (Meditech); Allscripts Healthcare Solutions; General Electric Company; Wolters Kluwer NV; and Others. They use business strategies such as mergers, acquisitions, collaborations, partnerships, and product launches to strengthen their hold on the market.
In April 2021, Change Healthcare launched InterQual 2021, which is a latest version of CDSS software. March 2020, International Business Machines Corporation (IBM) and Elton Bryson Stephens Company (EBSCO) entered a strategic collaboration to enhance clinical decision support and operations for health system and healthcare providers. In 2019, Cerner Corporation and Tenet Healthcare Corporation collaborated to make Cerner’s IT solutions highly effective across hospitals of Tenet Healthcare to increase engagement between patients and healthcare providers.